pomalidomide + drospirenone (contraceptive)

monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

pomalidomide + ethinyl estradiol (contraceptive)

monitor CBC, thrombosis s/sx: combo may incr. pomalidomide levels, risk of serious infection, myelosuppression, other adverse effects; may incr. risk of thromboembolism (hepatic metabolism inhibited; additive effects)